Angustin A exhibits significant anti-inflammatory properties, making it a candidate for development in treatments targeting chronic inflammatory diseases. It has been studied for its ability to inhibit key pro-inflammatory cytokines and suppress NF-κB signaling pathways in cellular models. Additionally, Angustin A demonstrates moderate antimicrobial activity against Gram-positive bacteria, suggesting potential use in topical antimicrobial formulations. Recent research also indicates neuroprotective effects in vitro, where it reduces oxidative stress in neuronal cells, pointing to possible applications in neurodegenerative disorder research. Its natural origin and bioactivity profile support further exploration in pharmaceutical and cosmeceutical fields.